Will joined The Cure Parkinson's Trust (CPT) as CEO in 2017, working with and alongside deputy CEO Helen Matthews, having been a trustee of the charity and chair of our Governance & Risk Committee since 2015. He also remains an active partner of intellectual property solicitors Marks & Clerk.

Will works closely with Helen and CPT’s Director of Research & Development Dr Richard Wyse to help drive the Trust’s innovative research programmes towards our goal: a cure for Parkinson’s. Richard, Helen and Will continue to lead the exciting progress the Trust is making on all fronts towards a cure with urgency and dedication.